Hong Yang Zhimin Liu Yufang Wang Jun Li Ruiqian Li Qilin Wang Chen Hu Haiyang Jiang Hongyi Wu Lele Song Yu Bai
10.1177/1758835920970845
Ther Adv Med Oncol
2020 Nov 11;12:1758835920970845.
brca1 brca2 parpi germline olaparib ureter urothelial carcinoma
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/33240400/
Case Reports
PMC7675892
33240400
Olaparib is effective for recurrent urothelial carcinoma with BRCA2 pathogenic germline mutation: first report on olaparib response in recurrent UC
2020